TY - JOUR
T1 - Total synthesis of the large non-ribosomal peptide polytheonamide B
AU - Inoue, Masayuki
AU - Shinohara, Naoki
AU - Tanabe, Shintaro
AU - Takahashi, Tomoaki
AU - Okura, Ken
AU - Itoh, Hiroaki
AU - Mizoguchi, Yuki
AU - Iida, Maiko
AU - Lee, Nayoung
AU - Matsuoka, Shigeru
N1 - Funding Information:
This work was supported financially by the Takeda Science Foundation and the Naito Foundation. Fellowships for N.S. and S.T. from the Japan Society for the Promotion of Science are gratefully acknowledged. We thank S. Matsunaga for providing the natural polytheonamides A and B, T. Hamada for valuable information, T. Katsuki for providing the catalyst and M. Hirama for valuable suggestions. The 800 MHz 1H NMR spectra were recorded at RIKEN SSBC, Yokohama, Japan.
PY - 2010/4
Y1 - 2010/4
N2 - Polytheonamide B is by far the largest non-ribosomal peptide known at present, and displays extraordinary cytotoxicity (EC50 =68 pg ml -1 , mouse leukaemia P388 cells). Its 48 amino-acid residues include a variety of non-proteinogenic d- and l-amino acids, and the absolute stereochemistry of these amino acids alternate in sequence. These structural features induce the formation of a stable β-strand-type structure, giving rise to an overall tubular structure over 30Å in length. In a biological setting, this fold is believed to transport cations across the lipid bilayer through a pore, thereby acting as an ion channel. Here, we report the first chemical construction of polytheonamide B. Our synthesis relies on the combination of four key stages: syntheses of non-proteinogenic amino acids, a solid-phase assembly of four fragments of polytheonamide B, silver-mediated connection of the fragments and, finally, global deprotection. The synthetic material now available will allow studies of the relationships between its conformational properties, channel functions and cytotoxicity.
AB - Polytheonamide B is by far the largest non-ribosomal peptide known at present, and displays extraordinary cytotoxicity (EC50 =68 pg ml -1 , mouse leukaemia P388 cells). Its 48 amino-acid residues include a variety of non-proteinogenic d- and l-amino acids, and the absolute stereochemistry of these amino acids alternate in sequence. These structural features induce the formation of a stable β-strand-type structure, giving rise to an overall tubular structure over 30Å in length. In a biological setting, this fold is believed to transport cations across the lipid bilayer through a pore, thereby acting as an ion channel. Here, we report the first chemical construction of polytheonamide B. Our synthesis relies on the combination of four key stages: syntheses of non-proteinogenic amino acids, a solid-phase assembly of four fragments of polytheonamide B, silver-mediated connection of the fragments and, finally, global deprotection. The synthetic material now available will allow studies of the relationships between its conformational properties, channel functions and cytotoxicity.
UR - http://www.scopus.com/inward/record.url?scp=77950283409&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77950283409&partnerID=8YFLogxK
U2 - 10.1038/nchem.554
DO - 10.1038/nchem.554
M3 - Article
C2 - 21124508
AN - SCOPUS:77950283409
VL - 2
SP - 280
EP - 285
JO - Nature Chemistry
JF - Nature Chemistry
SN - 1755-4330
IS - 4
ER -